A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases - Join Clinical Trial NCTNCT06342713
How to Join This Clinical Trial - NCTNCT06342713
Learn how to participate in this PHASE1 trial studying an investigational therapy for Healthy Participants, Healthy Subjects, Healthy Volunteers, Autoimmune Diseases, Healthy Adult Participants, Atopic Dermatitis, Prurigo Nodularis. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Healthy Participants, Healthy Subjects, Healthy Volunteers, Autoimmune Diseases, Healthy Adult Participants, Atopic Dermatitis, Prurigo Nodularis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Healthy Participants, Healthy Subjects, Healthy Volunteers, Autoimmune Diseases, Healthy Adult Participants, Atopic Dermatitis, Prurigo Nodularis
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1 - Early safety study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06342713 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 12 locations. Find a study site near you:
Clinical Research Site
Waitara, New South Wales NSW 2077 - Australia
Status: RECRUITING
Clinical Research Site
Adelaide, South Australia SA 5000 - Australia
Status: RECRUITING
Clinical Research Site
Beijing, Beijing 100000 - China
Status: RECRUITING
Clinical Research Site
Chongqing, Chongqing 630014 - China
Status: RECRUITING
Clinical Research Site
Guangzhou, Guangdong - China
Status: NOT_YET_RECRUITING
Clinical Research Site
Changsha, Hunan 410008 - China
Status: RECRUITING
Clinical Research Site
Shenyang, Liaoning 110001 - China
Status: RECRUITING
Clinical Research Site
Qingdao, Shandong 266555 - China
Status: RECRUITING
Clinical Research Site
Chengdu, Sichuan 610021 - China
Status: RECRUITING
Clinical Research Site
Auckland, 1010 - New Zealand
Status: RECRUITING
And 2 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE1 clinical trial for Healthy Participants, Healthy Subjects, Healthy Volunteers, Autoimmune Diseases, Healthy Adult Participants, Atopic Dermatitis, Prurigo Nodularis:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships